This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NI Technology Research Updates Outlooks For InvenSense, NXP Semiconductors, MIPS Technologies, Acacia Research, And OmniVision Technologies





PRINCETON, N.J., Feb. 23, 2012 /PRNewswire/ -- Next Inning Technology Research ( http://www.nextinning.com), an online investment newsletter focused on semiconductor and technology stocks, has published updated outlooks on InvenSense (NYSE: INVN), NXP Semiconductors (Nasdaq: NXPI), MIPS Technologies (Nasdaq: MIPS), Acacia Research (Nasdaq: ACTG), and OmniVision Technologies (Nasdaq: OVTI).

Next Inning readers leverage the insight you can only get from an industry insider.  Next Inning editor Paul McWilliams was a tech industry executive for more than two decades.  Not only does he know how things work from the inside and how to spot a winning business model, he also has a long and successful record of picking winning stocks.  Year to date in 2012 these picks have driven a 24% gain for the Next Inning Model Portfolio. Since its inception in 2002, the model portfolio is up over 300%.

It's a technology little-known outside high-tech labs and yet it offers the critical functions to power blockbuster consumer applications like Nintendo's Wii remote and Apple's iPhone and iPad microphones. Micro-electro-mechanical systems (MEMS) is a technology likely to see its huge growth continue, as next-generation entertainment systems and remote controls take advantage of this cutting-edge technology. McWilliams' latest report dissects the MEMS market from every angle, looking at recent "hot" IPO InvenSense as well as bigger players, as he identifies opportunities for investors to leverage these new developments. McWilliams' latest reports have the tech world buzzing, and they are now available via free trial subscription to Next Inning.

To get ahead of the Wall Street curve, you are invited to take a free, 21-day, no obligation trial with Next Inning.  For full details on this offer, please visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn1369

McWilliams covers these topics and more in his recent reports:

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs